Osciflex system imitates nature’s process to prevent deadly blood clots.
Osciflex has raised $1000K in total funding. The most recent round was Grant. The last funding was announced in December 2021.
Osciflex's investors include National Science Foundation, Ben Franklin Technology Partners of Southeastern Pennsylvania.
Osciflex is headquartered in Philadelphia, United States.
Osciflex system imitates nature’s process to prevent deadly blood clots.
Osciflex is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Osciflex — Funding & Investors." VCBacked, December 28, 2021, https://www.vcbacked.co/company/osciflex. Accessed August 14, 2026.
VCBacked. (2021). Osciflex — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/osciflex
{{cite web |title=Osciflex — Funding & Investors |url=https://www.vcbacked.co/company/osciflex |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated